Welcome |
 |
MCC is a comprehensive medical oncology, hematology and radiation oncology practice made up of a team of physicians, licensed therapists and oncology certified nurses. Our nine (9) board certified physicians have 160 years of combined experience to offer you.
Our treatment programs and research reinforce our commitment to quality patient care.
Latest Cancer News
Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer
(05-23-2013)
In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results... Continue Reading
Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug (05-22-2013)
Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by... Continue Reading
Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (05-22-2013)
Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22,... Continue Reading
In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results... Continue Reading
Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug (05-22-2013)
Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by... Continue Reading
Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (05-22-2013)
Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22,... Continue Reading
